Mountain View, CA – According to filings with the U.S. Securities and Exchange Commission, D2G Oncology is raising $8,749,952.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jonathan Macquitty played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About D2G Oncology

D2G Oncology is relating drugs to genotypes to transform precision cancer therapeutics.

To learn more about D2G Oncology, visit http://www.d2g-oncology.com/

Contact:
Jonathan Macquitty, Chief Executive Officer
650-804-8920

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved